Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Buys 88,314 Shares

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas bought 88,314 shares of Cosmos Health stock in a transaction dated Friday, December 19th. The shares were bought at an average cost of $0.49 per share, for a total transaction of $43,273.86. Following the completion of the transaction, the chief executive officer owned 6,716,771 shares of the company’s stock, valued at approximately $3,291,217.79. This trade represents a 1.33% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Grigorios Siokas also recently made the following trade(s):

• On Monday, December 15th, Grigorios Siokas acquired 168,472 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.42 per share, for a total transaction of $70,758.24.
• On Friday, November 28th, Grigorios Siokas acquired 76,360 shares of Cosmos Health stock. The shares were purchased at an average price of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The stock was purchased at an average price of $0.63 per share, with a total value of $35,111.16.
• On Friday, November 21st, Grigorios Siokas purchased 56,080 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.68 per share, for a total transaction of $38,134.40.
• On Thursday, November 20th, Grigorios Siokas purchased 51,315 shares of Cosmos Health stock. The shares were purchased at an average price of $0.62 per share, for a total transaction of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas acquired 61,614 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.65 per share, with a total value of $40,049.10.

Cosmos Health Trading Up 8.9%

NASDAQ COSM opened at $0.53 on Tuesday. Cosmos Health Inc. has a one year low of $0.28 and a one year high of $1.32. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.84 and a current ratio of 0.99. The company has a market capitalization of $18.51 million, a price-to-earnings ratio of -0.71 and a beta of 5.34. The company’s 50-day simple moving average is $0.71 and its two-hundred day simple moving average is $0.72.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.16). The business had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. Equities analysts forecast that Cosmos Health Inc. will post -0.78 EPS for the current fiscal year.

Institutional Investors Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Armistice Capital LLC lifted its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM) by 156.1% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 1,917,710 shares of the company’s stock after acquiring an additional 1,168,884 shares during the period. Armistice Capital LLC owned approximately 7.03% of Cosmos Health worth $836,000 at the end of the most recent quarter. Institutional investors and hedge funds own 12.61% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Wall Street Zen upgraded Cosmos Health to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Cosmos Health has a consensus rating of “Sell”.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.